Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Susan Ingram to Drug Tolerance

This is a "connection" page, showing publications Susan Ingram has written about Drug Tolerance.

 
Connection Strength
 
 
 
2.639
 
  1. Macey TA, Bobeck EN, Suchland KL, Morgan MM, Ingram SL. Change in functional selectivity of morphine with the development of antinociceptive tolerance. Br J Pharmacol. 2015 Jan; 172(2):549-61.
    View in: PubMed
    Score: 0.411
  2. Fyfe LW, Cleary DR, Macey TA, Morgan MM, Ingram SL. Tolerance to the antinociceptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons. J Pharmacol Exp Ther. 2010 Dec; 335(3):674-80.
    View in: PubMed
    Score: 0.315
  3. Morgan MM, Bobeck EN, Ingram SL. Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat. Brain Res. 2009 Oct 27; 1295:59-66.
    View in: PubMed
    Score: 0.293
  4. Ingram SL, Macey TA, Fossum EN, Morgan MM. Tolerance to repeated morphine administration is associated with increased potency of opioid agonists. Neuropsychopharmacology. 2008 Sep; 33(10):2494-504.
    View in: PubMed
    Score: 0.260
  5. Ingram SL, Fossum EN, Morgan MM. Behavioral and electrophysiological evidence for opioid tolerance in adolescent rats. Neuropsychopharmacology. 2007 Mar; 32(3):600-6.
    View in: PubMed
    Score: 0.236
  6. Morgan MM, Tierney BW, Ingram SL. Intermittent dosing prolongs tolerance to the antinociceptive effect of morphine microinjection into the periaqueductal gray. Brain Res. 2005 Oct 19; 1059(2):173-8.
    View in: PubMed
    Score: 0.224
  7. Ingram SL. Toward understanding the opioid paradox: cellular mechanisms of opioid-induced hyperalgesia. Neuropsychopharmacology. 2022 01; 47(2):427-428.
    View in: PubMed
    Score: 0.171
  8. Bobeck EN, Ingram SL, Hermes SM, Aicher SA, Morgan MM. Ligand-biased activation of extracellular signal-regulated kinase 1/2 leads to differences in opioid induced antinociception and tolerance. Behav Brain Res. 2016 Feb 01; 298(Pt B):17-24.
    View in: PubMed
    Score: 0.113
  9. Bobeck EN, Chen Q, Morgan MM, Ingram SL. Contribution of adenylyl cyclase modulation of pre- and postsynaptic GABA neurotransmission to morphine antinociception and tolerance. Neuropsychopharmacology. 2014 Aug; 39(9):2142-52.
    View in: PubMed
    Score: 0.101
  10. Mehalick ML, Ingram SL, Aicher SA, Morgan MM. Chronic inflammatory pain prevents tolerance to the antinociceptive effect of morphine microinjected into the ventrolateral periaqueductal gray of the rat. J Pain. 2013 Dec; 14(12):1601-10.
    View in: PubMed
    Score: 0.098
  11. Bobeck EN, Haseman RA, Hong D, Ingram SL, Morgan MM. Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat. J Pain. 2012 Aug; 13(8):799-807.
    View in: PubMed
    Score: 0.090
  12. Meyer PJ, Fossum EN, Ingram SL, Morgan MM. Analgesic tolerance to microinjection of the micro-opioid agonist DAMGO into the ventrolateral periaqueductal gray. Neuropharmacology. 2007 Jun; 52(8):1580-5.
    View in: PubMed
    Score: 0.062
  13. Morgan MM, Fossum EN, Levine CS, Ingram SL. Antinociceptive tolerance revealed by cumulative intracranial microinjections of morphine into the periaqueductal gray in the rat. Pharmacol Biochem Behav. 2006 Sep; 85(1):214-9.
    View in: PubMed
    Score: 0.060
  14. Ingram SL. Cellular and molecular mechanisms of opioid action. Prog Brain Res. 2000; 129:483-92.
    View in: PubMed
    Score: 0.038
  15. Bobeck EN, Schoo SM, Ingram SL, Morgan MM. Lack of Antinociceptive Cross-Tolerance With Co-Administration of Morphine and Fentanyl Into the Periaqueductal Gray of Male Sprague-Dawley Rats. J Pain. 2019 09; 20(9):1040-1047.
    View in: PubMed
    Score: 0.036
  16. Ingram SL, Vaughan CW, Bagley EE, Connor M, Christie MJ. Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J Neurosci. 1998 Dec 15; 18(24):10269-76.
    View in: PubMed
    Score: 0.035
  17. Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, Koch T, Evans CJ, Christie MJ. Regulation of ยต-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev. 2013 Jan; 65(1):223-54.
    View in: PubMed
    Score: 0.023
  18. Cyr MC, Ingram SL, Aicher SA, Morgan MM. Chronic psychostimulant exposure to adult, but not periadolescent rats reduces subsequent morphine antinociception. Pharmacol Biochem Behav. 2012 Jun; 101(4):538-43.
    View in: PubMed
    Score: 0.022
  19. Macey TA, Bobeck EN, Hegarty DM, Aicher SA, Ingram SL, Morgan MM. Extracellular signal-regulated kinase 1/2 activation counteracts morphine tolerance in the periaqueductal gray of the rat. J Pharmacol Exp Ther. 2009 Nov; 331(2):412-8.
    View in: PubMed
    Score: 0.018
  20. Morgan MM, Ashley MD, Ingram SL, Christie MJ. Behavioral consequences of delta-opioid receptor activation in the periaqueductal gray of morphine tolerant rats. Neural Plast. 2009; 2009:516328.
    View in: PubMed
    Score: 0.018
  21. Fossum EN, Lisowski MJ, Macey TA, Ingram SL, Morgan MM. Microinjection of the vehicle dimethyl sulfoxide (DMSO) into the periaqueductal gray modulates morphine antinociception. Brain Res. 2008 Apr 14; 1204:53-8.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)